Artio Medical Receives FDA’s 510(k) Clearance for Its Solus Gold Embolization Device

Artio Medical has received the FDA’s 510(k) marketing clearance for its Solus Gold embolization device for peripheral vascular occlusion.

The balloon-like implant obstructs the rate of blood flow in the peripheral vasculature following a controlled expansion and mechanical detachment. The device provides “precision placement and immediate occlusion, even in high-flow vessels,” the company said.

Kansas-based Artio Medical specializes in products for the peripheral vascular, neurovascular and cardiology markets.